BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19-47. [PMID: 23238534 DOI: 10.1097/tp.0b013e31827a19cc] [Cited by in Crossref: 525] [Cited by in F6Publishing: 144] [Article Influence: 58.3] [Reference Citation Analysis]
Number Citing Articles
1 Michel K, Santella R, Steers J, Sahajpal A, Downey FX, Thohan V, Oaks M. Many de novo donor-specific antibodies recognize β2 -microglobulin-free, but not intact HLA heterodimers. HLA 2016;87:356-66. [PMID: 27060279 DOI: 10.1111/tan.12775] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 Lefaucheur C, Viglietti D, Hidalgo LG, Ratner LE, Bagnasco SM, Batal I, Aubert O, Orandi BJ, Oppenheimer F, Bestard O, Rigotti P, Reisaeter AV, Kamar N, Lebranchu Y, Duong Van Huyen JP, Bruneval P, Glotz D, Legendre C, Empana JP, Jouven X, Segev DL, Montgomery RA, Zeevi A, Halloran PF, Loupy A. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. J Am Soc Nephrol 2018;29:620-35. [PMID: 29042454 DOI: 10.1681/ASN.2017050589] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 12.4] [Reference Citation Analysis]
3 Thaunat O, Koenig A, Leibler C, Grimbert P. Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant. J Am Soc Nephrol 2016;27:1890-900. [PMID: 26872489 DOI: 10.1681/ASN.2015070781] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 6.2] [Reference Citation Analysis]
4 Bharat A, Mohanakumar T. Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection. J Immunol Res 2017;2017:6312514. [PMID: 28164137 DOI: 10.1155/2017/6312514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
5 Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016;374:940-950. [PMID: 26962729 DOI: 10.1056/nejmoa1508380] [Cited by in Crossref: 202] [Cited by in F6Publishing: 76] [Article Influence: 33.7] [Reference Citation Analysis]
6 Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG. Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant. Am J Transplant 2018;18:2274-84. [PMID: 29464832 DOI: 10.1111/ajt.14709] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
7 Wu GS, Cruz Jr RJ, Cai JC. Acute antibody-mediated rejection after intestinal transplantation. World J Transplant 2016; 6(4): 719-728 [PMID: 28058223 DOI: 10.5500/wjt.v6.i4.719] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
8 Focosi D. Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside. Int Rev Immunol 2016;35:351-68. [PMID: 27120091 DOI: 10.3109/08830185.2016.1154051] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB. The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant 2014;14:779-87. [PMID: 24580828 DOI: 10.1111/ajt.12667] [Cited by in Crossref: 133] [Cited by in F6Publishing: 117] [Article Influence: 16.6] [Reference Citation Analysis]
10 Hibi T, Shinoda M, Itano O, Kitagawa Y. Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis 2014;10:241-9. [PMID: 24836922 DOI: 10.4161/org.29245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bettinotti MP, Zachary AA, Leffell MS. Clinically relevant interpretation of solid phase assays for HLA antibody. Curr Opin Organ Transplant 2016;21:453-8. [PMID: 27200498 DOI: 10.1097/MOT.0000000000000326] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 3.4] [Reference Citation Analysis]
12 Filippone EJ, Farber JL. The specificity of acute and chronic microvascular alterations in renal allografts. Clin Transplant 2013;27:790-8. [PMID: 24118527 DOI: 10.1111/ctr.12258] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
13 Arnau A, Benito-Hernández A, Ramos-Barrón MA, García-Unzueta MT, Gómez-Román JJ, Gómez-Ortega JM, López-Hoyos M, San Segundo D, Ruiz JC, Rodrigo E. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage. Ann Transplant 2021;26:e929491. [PMID: 33686050 DOI: 10.12659/AOT.929491] [Reference Citation Analysis]
14 Gül-Klein S, Hegermann H, Röhle R, Schmelzle M, Tacke F, Schöning W, Öllinger R, Dziodzio T, Maier P, Plewe JM, Horst D, Sauer IM, Pratschke J, Lachmann N, Eurich D. Donor-Specific Antibodies Against Donor Human Leukocyte Antigen are Associated with Graft Inflammation but Not with Fibrosis Long-Term After Liver Transplantation: An Analysis of Protocol Biopsies. J Inflamm Res 2021;14:2697-712. [PMID: 34188517 DOI: 10.2147/JIR.S307778] [Reference Citation Analysis]
15 Martuszewski A, Paluszkiewicz P, Król M, Banasik M, Kepinska M. Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review. J Clin Med 2021;10:E193. [PMID: 33430458 DOI: 10.3390/jcm10020193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Baker RJ, Mark PB, Patel RK, Stevens KK, Palmer N. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 2017;18:174. [PMID: 28571571 DOI: 10.1186/s12882-017-0553-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 11.4] [Reference Citation Analysis]
17 Sakamoto S, Iwasaki K, Tomosugi T, Niemann M, Spierings E, Miwa Y, Horimi K, Takeda A, Goto N, Narumi S, Watarai Y, Kobayashi T. Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study. Front Immunol 2020;11:2000. [PMID: 32973806 DOI: 10.3389/fimmu.2020.02000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Abbes S, Metjian A, Gray A, Martinu T, Snyder L, Chen DF, Ellis M, Arepally GM, Onwuemene O. Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. Ther Apher Dial 2017;21:441-50. [PMID: 28880430 DOI: 10.1111/1744-9987.12570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
19 Waldecker CB, Zgoura P, Seibert FS, Gall S, Schenker P, Bauer F, Rohn B, Viebahn R, Babel N, Westhoff TH. Biopsy findings after detection of de novo donor-specific antibodies in renal transplant recipients: a single center experience. J Nephrol 2021. [PMID: 33866524 DOI: 10.1007/s40620-021-01040-y] [Reference Citation Analysis]
20 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Kim SC, Pearson TC, Tso PL. Revamped Rationing of Renal Resources: Kidney Allocation in Search of Utility and Justice for All. Curr Transpl Rep 2015;2:135-43. [DOI: 10.1007/s40472-015-0050-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Irure J, Asensio E, Rodrigo E, Romón Í, Gómez J, Arias M, López-Hoyos M, San Segundo D. Improvement in the definition of anti-HLA antibody profile in highly sensitized patients. PLoS One 2017;12:e0171463. [PMID: 28158255 DOI: 10.1371/journal.pone.0171463] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zeevi A. Chronic antibody-mediated rejection: new diagnostic tools - clinical significance of C4d deposition and improved detection and characterization of human leucocyte antigen antibodies. Clin Exp Immunol 2014;178 Suppl 1:52-3. [PMID: 25546760 DOI: 10.1111/cei.12509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Mendoza Rojas A, van Gelder T, de Kuiper R, Reijerkerk D, Clahsen-van Groningen MC, Hesselink DA, Baan CC, van Besouw NM. Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection. Sci Rep 2021;11:12445. [PMID: 34127739 DOI: 10.1038/s41598-021-91967-w] [Reference Citation Analysis]
25 Nowańska K, Wiśnicki K, Kuriata-Kordek M, Krajewska M, Banasik M. The role of endothelin II type A receptor (ETAR) in transplant injury. Transpl Immunol 2021;70:101505. [PMID: 34793957 DOI: 10.1016/j.trim.2021.101505] [Reference Citation Analysis]
26 Dick A, Humpe A, Kauke T. Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation. Transfus Med Hemother 2019;46:337-47. [PMID: 31832059 DOI: 10.1159/000502124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 Gil BC, Kulzer ASS, de Moraes P, Toresan R, da Rosa Vicari A, Dos Santos Fagundes I, Merzoni J, Ewald GM, Cardone JM, Silva FG, Manfro RC, Jobim LF. Comparative analysis of two methods to detect donor-specific anti-HLA antibodies after kidney transplant. Transpl Immunol 2018;49:7-11. [PMID: 29577967 DOI: 10.1016/j.trim.2018.03.006] [Reference Citation Analysis]
28 Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, König IR, Kurschat C, Lehmann C, Marget M, Mühlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Süsal C, Thiele B, Zecher D, Lachmann N. Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. Clin J Am Soc Nephrol 2019;14:1056-66. [PMID: 31213508 DOI: 10.2215/CJN.13401118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
29 Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation 2015;99:1156-64. [PMID: 25629531 DOI: 10.1097/TP.0000000000000511] [Cited by in Crossref: 41] [Cited by in F6Publishing: 11] [Article Influence: 5.9] [Reference Citation Analysis]
30 Maier M, Takano T, Sapir-Pichhadze R. Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis 2017;4:2054358116688227. [PMID: 28270929 DOI: 10.1177/2054358116688227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
31 Sommerwerck U, Rabis T, Fleimisch P, Carstens H, Teschler H, Kamler M. [Lung transplantation]. Herz 2014;39:74-83. [PMID: 24477632 DOI: 10.1007/s00059-013-4044-3] [Reference Citation Analysis]
32 Tait BD. Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay. Front Immunol 2016;7:570. [PMID: 28018342 DOI: 10.3389/fimmu.2016.00570] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
33 Konvalinka A, Tinckam K. Utility of HLA Antibody Testing in Kidney Transplantation. J Am Soc Nephrol. 2015;26:1489-1502. [PMID: 25804279 DOI: 10.1681/asn.2014080837] [Cited by in Crossref: 103] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
34 Stites E, Le Quintrec M, Thurman JM. The Complement System and Antibody-Mediated Transplant Rejection. J Immunol 2015;195:5525-31. [PMID: 26637661 DOI: 10.4049/jimmunol.1501686] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
35 Bedford A, Jervis S, Worthington J, Lowe M, Poulton K. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation. Int J Immunogenet 2021. [PMID: 34904369 DOI: 10.1111/iji.12563] [Reference Citation Analysis]
36 Mota MA. Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality. Rev Bras Hematol Hemoter 2013;35:160-1. [PMID: 23904801 DOI: 10.5581/1516-8484.20130046] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Katalinić N, Starčević A, Mavrinac M, Balen S. Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events. Clin Kidney J 2017;10:852-8. [PMID: 29225816 DOI: 10.1093/ckj/sfx050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Butler CL, Hickey MJ, Jiang N, Zheng Y, Gjertson D, Zhang Q, Rao P, Fishbein GA, Cadeiras M, Deng MC, Banchs HL, Torre G, DeNofrio D, Eisen HJ, Kobashigawa J, Starling RC, Kfoury A, Van Bakel A, Ewald G, Balazs I, Baas AS, Cruz D, Ardehali R, Biniwale R, Kwon M, Ardehali A, Nsair A, Ray B, Reed EF. Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside. Am J Transplant 2020;20:2768-80. [PMID: 32185871 DOI: 10.1111/ajt.15863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
39 Wu GS. Updates on antibody-mediated rejection in intestinal transplantation. World J Transplant 2016; 6(3): 564-572 [PMID: 27683635 DOI: 10.5500/wjt.v6.i3.564] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Morris AA, Butler J. Reply: Ethnic diversity and immunological barriers in heart transplantation. J Am Coll Cardiol 2014;63:2172. [PMID: 24657686 DOI: 10.1016/j.jacc.2014.02.550] [Reference Citation Analysis]
41 Platt JL, Cascalho M, Piedrahita JA. Xenotransplantation: Progress Along Paths Uncertain from Models to Application. ILAR J. 2018;59:286-308. [PMID: 30541147 DOI: 10.1093/ilar/ily015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Wiebe C, Kosmoliaptsis V, Pochinco D, Gibson IW, Ho J, Birk PE, Goldberg A, Karpinski M, Shaw J, Rush DN, Nickerson PW. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity. Am J Transplant 2019;19:1708-19. [PMID: 30414349 DOI: 10.1111/ajt.15177] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
43 Kamburova EG, Hoitsma A, Claas FH, Otten HG; PROCARE Consortium. Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: A mini-review. HLA 2019;94:129-40. [PMID: 31099989 DOI: 10.1111/tan.13581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Süsal C, Opelz G, Morath C. Role and Value of Luminex(®)-Detected HLA Antibodies before and after Kidney Transplantation. Transfus Med Hemother 2013;40:190-5. [PMID: 23922544 DOI: 10.1159/000351314] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
45 Wehmeier C, Karahan GE, Heidt S. HLA-specific memory B-cell detection in kidney transplantation: Insights and future challenges. Int J Immunogenet 2020;47:227-34. [PMID: 32390325 DOI: 10.1111/iji.12493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Bruneval P, Angelini A, Miller D, Potena L, Loupy A, Zeevi A, Reed EF, Dragun D, Reinsmoen N, Smith RN, West L, Tebutt S, Thum T, Haas M, Mengel M, Revelo P, Fedrigo M, Duong Van Huyen JP, Berry GJ. The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated Rejection Diagnostics: Strengths, Unmet Needs, and Future Directions. Am J Transplant 2017;17:42-53. [PMID: 27862968 DOI: 10.1111/ajt.14112] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
47 Süsal C, Döhler B, Ruhenstroth A, Morath C, Slavcev A, Fehr T, Wagner E, Krüger B, Rees M, Balen S, Živčić-Ćosić S, Norman DJ, Kuypers D, Emonds MP, Pisarski P, Bösmüller C, Weimer R, Mytilineos J, Scherer S, Tran TH, Gombos P, Schemmer P, Zeier M, Opelz G; A Collaborative Transplant Study Report. Donor-specific antibodies require preactivated immune system to harm renal transplant. EBioMedicine 2016;9:366-71. [PMID: 27333031 DOI: 10.1016/j.ebiom.2016.06.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
48 Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Bensussan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R. Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Sci Rep 2017;7:41125. [PMID: 28117403 DOI: 10.1038/srep41125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
49 Passamonti SM, Cannavò A, Espadas de Arias A, Innocente A, Ramondetta M, Regalia A, Messa P, Ferraresso M, Cardillo M. Pretransplant Single Antigen Bead-Detected HLA Antibodies in Kidney Transplant Long-term Outcome: A Single-Center Cohort Experience. Transplant Proc 2019;51:707-14. [PMID: 30979454 DOI: 10.1016/j.transproceed.2019.01.063] [Reference Citation Analysis]
50 Fichtner A, Süsal C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Opelz G, Tönshoff B. Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients. Pediatr Nephrol 2016;31:1157-66. [PMID: 26928311 DOI: 10.1007/s00467-016-3322-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
51 Peacock S, Briggs D, Barnardo M, Battle R, Brookes P, Callaghan C, Clark B, Collins C, Day S, Diaz Burlinson N, Dunn P, Fernando R, Fuggle S, Harmer A, Kallon D, Keegan D, Key T, Lawson E, Lloyd S, Martin J, McCaughan J, Middleton D, Partheniou F, Poles A, Rees T, Sage D, Santos-Nunez E, Shaw O, Willicombe M, Worthington J. BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation. Int J Immunogenet 2021. [PMID: 34555264 DOI: 10.1111/iji.12558] [Reference Citation Analysis]
52 Süsal C. Increasing relevance of histocompatibility testing in organ transplantation. Curr Opin Organ Transplant 2013;18:436-7. [PMID: 23774634 DOI: 10.1097/MOT.0b013e32836370e8] [Reference Citation Analysis]
53 Ortiz MA, Álvarez CM, Arrunátegui AM, Arias YR, Villegas A. Immunological follow-up of patients with renal transplants: A proposal for clinical practice in Colombia. Biomedica 2020;40:479-86. [PMID: 33030826 DOI: 10.7705/biomedica.5092] [Reference Citation Analysis]
54 Blatter J, Sweet S. Lung Transplantation in Cystic Fibrosis: Trends and Controversies. Pediatr Allergy Immunol Pulmonol 2015;28:237-43. [PMID: 26697265 DOI: 10.1089/ped.2015.0564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
55 Dedinská I, Mäčková N, Macháleková K, Miklušica J, Palkoci B, Fialová J, Čellár M, Galajda P, Mokáň M. Flow Cytometry Panel-Reactive Antibody Screening of Anti-HLA Antibodies in the Waiting List Significantly Reduces the Occurrence of Acute Rejection After Kidney Transplantation. Transplant Proc 2017;49:1719-23. [PMID: 28923614 DOI: 10.1016/j.transproceed.2017.04.016] [Reference Citation Analysis]
56 Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, Quartuccio G, Fontana I, Magnasco A, Drago F, Gurrado A, Guido I, Compagno F, Garibotto G, Klersy C, Verrina E, Ghiggeri GM, Cardillo M, Comoli P, Ginevri F. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients. J Immunol Res 2017;2017:1747030. [PMID: 28367453 DOI: 10.1155/2017/1747030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
57 Salcido-Ochoa F, Allen Jr JC. Biomarkers and a tailored approach for immune monitoring in kidney transplantation. World J Transplant 2017; 7(6): 276-284 [PMID: 29312857 DOI: 10.5500/wjt.v7.i6.276] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
58 Mahdi BM. A glow of HLA typing in organ transplantation. Clin Transl Med 2013;2:6. [PMID: 23432791 DOI: 10.1186/2001-1326-2-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
59 Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasińska A, Rabant M, Racusen LC, Solez K, Becker JU. A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation 2018;102:1795-814. [PMID: 30028786 DOI: 10.1097/TP.0000000000002366] [Cited by in Crossref: 174] [Cited by in F6Publishing: 88] [Article Influence: 58.0] [Reference Citation Analysis]
60 Patri P, Seshan SV, Matignon M, Desvaux D, Lee JR, Lee J, Dadhania DM, Serur D, Grimbert P, Hartono C, Muthukumar T. Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy. Kidney Int 2016;89:450-8. [PMID: 26422505 DOI: 10.1038/ki.2015.288] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
61 Fasano RM, Sullivan HC, Bray RA, Gebel HM, Meyer EK, Winkler AM, Josephson CD, Stowell SR, Sandy Duncan A, Roback JD. Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience. Arch Pathol Lab Med 2017;141:329-40. [PMID: 28234571 DOI: 10.5858/arpa.2016-0277-SA] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 3.6] [Reference Citation Analysis]
62 Karahan GE, Claas FHJ, Heidt S. Pre-existing Alloreactive T and B Cells and Their Possible Relevance for Pre-transplant Risk Estimation in Kidney Transplant Recipients. Front Med (Lausanne) 2020;7:340. [PMID: 32793610 DOI: 10.3389/fmed.2020.00340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Kim SC, Foley DP. Donor-specific antibodies in liver transplantation: challenges in diagnosis and determining clinical impact. Curr Opin Organ Transplant 2020;25:549-54. [PMID: 33105198 DOI: 10.1097/MOT.0000000000000825] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Matsuda Y, Sarwal MM. Unraveling the Role of Allo-Antibodies and Transplant Injury. Front Immunol 2016;7:432. [PMID: 27818660 DOI: 10.3389/fimmu.2016.00432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
65 Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg HJ. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies. Ann Am Thorac Soc 2019;16:1131-7. [PMID: 31026404 DOI: 10.1513/AnnalsATS.201812-869OC] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
66 Yamada C, Ramon DS, Cascalho M, Sung RS, Leichtman AB, Samaniego M, Davenport RD. Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion 2015;55:727-35; quiz 726. [PMID: 25385678 DOI: 10.1111/trf.12923] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
67 O'Leary JG, Michelle Shiller S, Bellamy C, Nalesnik MA, Kaneku H, Jennings LW, Isse K, Terasaki PI, Klintmalm GB, Demetris AJ. Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features. Liver Transpl 2014;20:1244-55. [PMID: 25045154 DOI: 10.1002/lt.23948] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
68 Becker JU, Baba HA. [Report from the working group on cardiac, vascular, renal and transplantation pathology 2014]. Pathologe 2014;35 Suppl 2:289-90. [PMID: 25394981 DOI: 10.1007/s00292-014-2014-z] [Reference Citation Analysis]
69 Siegl J, Nikolin C, Phung NL, Thoms S, Blume C, Mayer G. Split-Combine Click-SELEX Reveals Ligands Recognizing the Transplant Rejection Biomarker CXCL9. ACS Chem Biol 2022. [PMID: 35018777 DOI: 10.1021/acschembio.1c00789] [Reference Citation Analysis]
70 Philogene MC, Zachary AA. Assessing immunologic risk factors in transplantation. Expert Rev Clin Immunol 2013;9:773-9. [PMID: 23971755 DOI: 10.1586/1744666X.2013.814413] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Nowańska K, Banasik M, Donizy P, Kościelska-Kasprzak K, Zmonarski S, Letachowicz K, Kamińska D, Mazanowska O, Augustyniak-Bartosik H, Tukiendorf A, Chudiak A, Dawiskiba T, Hałoń A, Krajewska M. Endothelin A Receptors Expressed in Glomeruli of Renal Transplant Patients May Be Associated with Antibody-Mediated Rejection. J Clin Med 2021;10:422. [PMID: 33499235 DOI: 10.3390/jcm10030422] [Reference Citation Analysis]
72 Dandel M, Hetzer R. Non-invasive cardiac allograft rejection surveillance: reliability and clinical value for prevention of heart failure. Heart Fail Rev 2021;26:319-36. [PMID: 32889634 DOI: 10.1007/s10741-020-10023-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Dreyer GJ, de Fijter JW. Transplanting the Elderly: Mandatory Age- and Minimal Histocompatibility Matching. Front Immunol 2020;11:359. [PMID: 32226428 DOI: 10.3389/fimmu.2020.00359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
74 Arreola-Guerra JM, Castelán N, de Santiago A, Arvizu A, Gonzalez-Tableros N, López M, Salcedo I, Vilatobá M, Granados J, Morales-Buenrostro LE, Alberú J. C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch. J Transplant 2016;2016:2106028. [PMID: 27688904 DOI: 10.1155/2016/2106028] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
75 Salvadori M, Bertoni E. Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant 2014; 4(1): 1-17 [PMID: 24669363 DOI: 10.5500/wjt.v4.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
76 Viglietti D, Loupy A, Vernerey D, Bentlejewski C, Gosset C, Aubert O, Duong van Huyen JP, Jouven X, Legendre C, Glotz D, Zeevi A, Lefaucheur C. Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. J Am Soc Nephrol 2017;28:702-15. [PMID: 27493255 DOI: 10.1681/ASN.2016030368] [Cited by in Crossref: 83] [Cited by in F6Publishing: 34] [Article Influence: 13.8] [Reference Citation Analysis]
77 Schinstock CA, Gandhi MJ, Stegall MD. Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians. Transplantation 2016;100:1619-28. [PMID: 27140516 DOI: 10.1097/TP.0000000000001203] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 5.8] [Reference Citation Analysis]
78 Giarraputo A, Barison I, Fedrigo M, Burrello J, Castellani C, Tona F, Bottio T, Gerosa G, Barile L, Angelini A. A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring. Biomolecules 2021;11:201. [PMID: 33535640 DOI: 10.3390/biom11020201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Nayak DK, Saravanan PB, Bansal S, Naziruddin B, Mohanakumar T. Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. Front Immunol 2016;7:650. [PMID: 28066448 DOI: 10.3389/fimmu.2016.00650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
80 McCaughan J, Xu Q, Tinckam K. Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff. Hepatobiliary Surg Nutr 2019;8:37-52. [PMID: 30881964 DOI: 10.21037/hbsn.2019.01.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
81 Hammond MEH, Stehlik J, Drakos SG, Kfoury AG. Bias in Medicine: Lessons Learned and Mitigation Strategies. JACC Basic Transl Sci 2021;6:78-85. [PMID: 33532668 DOI: 10.1016/j.jacbts.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Andrade-Sierra J, Cueto-Manzano AM, Rojas-Campos E, Cardona-Muñoz E, Cerrillos-Gutiérrez JI, González-Espinoza E, Evangelista-Carrillo LA, Medina-Pérez M, Jalomo-Martínez B, Nieves Hernández J, Pazarín-Villaseñor L, Mendoza-Cerpa CA, Gómez-Navarro B, Miranda-Díaz AG. Donor-specific antibodies development in renal living-donor receptors: Effect of a single cohort. Int J Immunopathol Pharmacol 2021;35:20587384211000545. [PMID: 33787382 DOI: 10.1177/20587384211000545] [Reference Citation Analysis]
83 Blumberg JM, Gritsch HA, Reed EF, Cecka JM, Lipshutz GS, Danovitch GM, McGuire S, Gjertson DW, Veale JL. Kidney paired donation in the presence of donor-specific antibodies. Kidney Int. 2013;84:1009-1016. [PMID: 23715120 DOI: 10.1038/ki.2013.206] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
84 Oh EJ, Park H, Park KU, Kang ES, Kim HS, Song EY. Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection. Ann Lab Med 2015;35:321-8. [PMID: 25932440 DOI: 10.3343/alm.2015.35.3.321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
85 Seifert ME, Yanik MV, Feig DI, Hauptfeld-Dolejsek V, Mroczek-Musulman EC, Kelly DR, Rosenblum F, Mannon RB. Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation. Am J Transplant 2018;18:2189-99. [PMID: 29766640 DOI: 10.1111/ajt.14933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
86 Beyzaei Z, Geramizadeh B, Bagheri Z, Karimzadeh S, Shojazadeh A. De Novo Donor Specific Antibody and Long-Term Outcome After Liver Transplantation: A Systematic Review and Meta-Analysis. Front Immunol 2020;11:613128. [PMID: 33424868 DOI: 10.3389/fimmu.2020.613128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant 2014;14:255-71. [PMID: 24401076 DOI: 10.1111/ajt.12589] [Cited by in Crossref: 241] [Cited by in F6Publishing: 201] [Article Influence: 30.1] [Reference Citation Analysis]
88 Weitzel KW, Aquilante CL, Johnson S, Kisor DF, Empey PE. Educational strategies to enable expansion of pharmacogenomics-based care. Am J Health Syst Pharm 2016;73:1986-98. [PMID: 27864206 DOI: 10.2146/ajhp160104] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
89 Brokhof MM, Sollinger HW, Hager DR, Muth BL, Pirsch JD, Fernandez LA, Bellingham JM, Mezrich JD, Foley DP, D'Alessandro AM, Odorico JS, Mohamed MA, Vidyasagar V, Ellis TM, Kaufman DB, Djamali A. Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients. Transplantation 2014;97:612-7. [PMID: 24531846 DOI: 10.1097/TP.0000000000000031] [Cited by in Crossref: 56] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
90 In JW, Roh EY, Shin S, Park KU, Song EY. Evaluation of Changes in New Calculated Panel Reactive Antibody Adopting HLA-Cw, DR51/52/53, and DQ Antigens in Koreans. Transplant Proc 2016;48:766-9. [PMID: 27234731 DOI: 10.1016/j.transproceed.2015.12.124] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
91 Higgins RSD, Kilic A, Tang DG. Surgical Treatment of Heart Failure. Surg Clin North Am 2017;97:923-46. [PMID: 28728723 DOI: 10.1016/j.suc.2017.04.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
92 Otten HG, Verhaar MC, Borst HP, van Eck M, van Ginkel WG, Hené RJ, van Zuilen AD. The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation. Clin Exp Immunol 2013;173:536-43. [PMID: 23627692 DOI: 10.1111/cei.12127] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
93 Eby BC, Redfield RR, Ellis TM, Leverson GE, Schenian AR, Odorico JS. Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata. Transplantation 2016;100:1103-10. [PMID: 26950720 DOI: 10.1097/TP.0000000000001125] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 3.2] [Reference Citation Analysis]
94 Mangiola M, Marrari M, Feingold B, Zeevi A. Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes. Front Immunol 2017;8:4. [PMID: 28191005 DOI: 10.3389/fimmu.2017.00004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
95 de Castro MCR, Barbosa EA, Souza RP, Agena F, de Souza PS, Maciel G, Rodrigues H, Panajotopoulos N, David DS, de Paula FJ, David-Neto E. The Kinetics of Anti-HLA Antibodies in the First Year after Kidney Transplantation: In Whom and When Should They Be Monitored? J Transplant 2018;2018:8316860. [PMID: 29850195 DOI: 10.1155/2018/8316860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Philogene MC, Bagnasco S, Kraus ES, Montgomery RA, Dragun D, Leffell MS, Zachary AA, Jackson AM. Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. Transplantation 2017;101:608-15. [PMID: 27222934 DOI: 10.1097/TP.0000000000001231] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
97 Karahan GE, Eikmans M, Anholts JD, Claas FH, Heidt S. Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells. Clin Exp Immunol 2014;177:333-40. [PMID: 24611883 DOI: 10.1111/cei.12305] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
98 Zachary AA, Leffell MS. HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act. Front Immunol 2016;7:575. [PMID: 28003816 DOI: 10.3389/fimmu.2016.00575] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
99 Young KA, Ali HA, Beermann KJ, Reynolds JM, Snyder LD. Lung Transplantation and the Era of the Sensitized Patient. Front Immunol 2021;12:689420. [PMID: 34122454 DOI: 10.3389/fimmu.2021.689420] [Reference Citation Analysis]
100 O'Leary JG, Kaneku H, Demetris AJ, Marr JD, Shiller SM, Susskind BM, Tillery GW, Terasaki PI, Klintmalm GB. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss. Liver Transpl 2014;20:218-27. [PMID: 24382837 DOI: 10.1002/lt.23788] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 9.3] [Reference Citation Analysis]
101 Filippone EJ, Farber JL. The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies. J Immunol Res 2016;2016:5197396. [PMID: 28070526 DOI: 10.1155/2016/5197396] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
102 Moszkowska G, Zielińska H, Zieliński M, Dukat-Mazurek A, Dębska-Zielkowska J, Lewandowska D, Durlik M, Dębska-Ślizień A, Trzonkowski P. Immune Algorithm Optimization for Organ Transplantation in Poland. Transplant Proc 2020;52:2026-32. [PMID: 32279916 DOI: 10.1016/j.transproceed.2020.02.082] [Reference Citation Analysis]
103 Bröcker V, Mengel M. Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation. Pediatr Nephrol 2014;29:1939-49. [PMID: 24141526 DOI: 10.1007/s00467-013-2640-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
104 Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology. Am J Transplant. 2017;17:28-41. [PMID: 27862883 DOI: 10.1111/ajt.14107] [Cited by in Crossref: 375] [Cited by in F6Publishing: 342] [Article Influence: 75.0] [Reference Citation Analysis]
105 Jordan SC, Bunnapradist S, Bromberg JS, Langone AJ, Hiller D, Yee JP, Sninsky JJ, Woodward RN, Matas AJ. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients. Transplant Direct 2018;4:e379. [PMID: 30234148 DOI: 10.1097/TXD.0000000000000821] [Cited by in Crossref: 44] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
106 Hanf W, Bonder CS, Coates PT. Transplant glomerulopathy: the interaction of HLA antibodies and endothelium. J Immunol Res 2014;2014:549315. [PMID: 24741606 DOI: 10.1155/2014/549315] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
107 Morath C, Opelz G, Zeier M, Süsal C. Clinical relevance of HLA antibody monitoring after kidney transplantation. J Immunol Res 2014;2014:845040. [PMID: 25374891 DOI: 10.1155/2014/845040] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
108 Tanrısev M, Ayna Kılıçaslan T, Çolak H, Ersan S, Yılmaz B, Alp A, Tuğmen C, Sevgili BE. Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions. Ann Transplant 2021;26:e932434. [PMID: 34531361 DOI: 10.12659/AOT.932434] [Reference Citation Analysis]
109 Leffell MS, Jones RJ, Gladstone DE. Donor HLA-specific Abs: to BMT or not to BMT? Bone Marrow Transplant 2015;50:751-8. [PMID: 25706884 DOI: 10.1038/bmt.2014.331] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
110 Win TS, Murakami N, Borges TJ, Chandraker A, Murphy G, Lian C, Barrera V, Ho Sui S, Schoenfeld D, Teague J, Bueno E, Tullius SG, Pomahac B, Clark RA, Riella LV. Longitudinal immunological characterization of the first presensitized recipient of a face transplant. JCI Insight 2017;2:93894. [PMID: 28679959 DOI: 10.1172/jci.insight.93894] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
111 Bharat A, Chiu S, Zheng Z, Sun H, Yeldandi A, DeCamp MM, Perlman H, Budinger GR, Mohanakumar T. Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation. Am J Respir Cell Mol Biol 2016;55:532-41. [PMID: 27144500 DOI: 10.1165/rcmb.2016-0077OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
112 Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Almeida M, Pedroso S, Freitas F, Beirão I, Castro Henriques A, Cabrita A. Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipients. Biomed Res Int 2014;2014:438945. [PMID: 24839605 DOI: 10.1155/2014/438945] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
113 Lasmar MF, Dutra RS, Nogueira-Machado JA, Fabreti-Oliveira RA, Siqueira RG, Nascimento E. Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection. BMC Nephrol 2019;20:314. [PMID: 31409321 DOI: 10.1186/s12882-019-1497-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
114 Liu C, Pang S, Phelan D, Brennan DC, Mohanakumar T. Quantitative Evaluation of the Impact of Ethylenediaminetetraacetic Acid Pretreatment on Single-Antigen Bead Assay. Transplant Direct 2017;3:e194. [PMID: 28795145 DOI: 10.1097/TXD.0000000000000709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
115 Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG. Antibodies against ARHGDIB are associated with long-term kidney graft loss. Am J Transplant 2019;19:3335-44. [PMID: 31194283 DOI: 10.1111/ajt.15493] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
116 Abramowicz D, Oberbauer R, Heemann U, Viklicky O, Peruzzi L, Mariat C, Crespo M, Budde K, Oniscu GC. Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board. Nephrol Dial Transplant. 2018;33:1699-1707. [PMID: 29342289 DOI: 10.1093/ndt/gfx365] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
117 Jucaud V, Ravindranath MH, Terasaki PI. Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions. Transplantation 2017;101:764-77. [PMID: 27495776 DOI: 10.1097/TP.0000000000001420] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
118 Dijke EI, Platt JL, Blair P, Clatworthy MR, Patel JK, Kfoury AG, Cascalho M. B cells in transplantation. J Heart Lung Transplant 2016;35:704-10. [PMID: 26996930 DOI: 10.1016/j.healun.2016.01.1232] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
119 Ciurea SO, Thall PF, Milton DR, Barnes TH, Kongtim P, Carmazzi Y, López AA, Yap DY, Popat U, Rondon G, Lichtiger B, Aung F, Afshar-Kharghan V, Ma Q, Fernández-Viña M, Champlin RE, Cao K. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2015;21:1392-8. [PMID: 25985919 DOI: 10.1016/j.bbmt.2015.05.001] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 12.3] [Reference Citation Analysis]
120 Hirai T, Furusawa M, Omoto K, Ishida H, Tanabe K. The authors' reply. Transplantation 2014;98:e31-2. [PMID: 25243518 DOI: 10.1097/TP.0000000000000352] [Reference Citation Analysis]
121 Pearl MH, Zhang Q, Palma Diaz MF, Grotts J, Rossetti M, Elashoff D, Gjertson DW, Weng P, Reed EF, Tsai Chambers E. Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. Kidney Int 2018;93:260-9. [PMID: 28927645 DOI: 10.1016/j.kint.2017.06.034] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
122 Rees L, Kim JJ. HLA sensitisation: can it be prevented? Pediatr Nephrol 2015;30:577-87. [PMID: 25062962 DOI: 10.1007/s00467-014-2868-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
123 Kim JJ, Shaw O, Martin C, Michaelides G, Balasubramaniam R, Sebire NJ, Mamode N, Dorling A, Vaughan R, Marks SD. Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies. Pediatr Nephrol 2018;33:167-74. [PMID: 28918487 DOI: 10.1007/s00467-017-3772-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
124 Katalinić N, Fućak M, Crnić T, Ćurković M, Starčević A, Balen S. Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays. Wien Klin Wochenschr 2017;129:33-7. [PMID: 27743177 DOI: 10.1007/s00508-016-1094-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
125 Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients. Ann Lab Med 2018;38:450-7. [PMID: 29797816 DOI: 10.3343/alm.2018.38.5.450] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
126 Higgins RM, Daga S, Mitchell DA. Antibody-incompatible kidney transplantation in 2015 and beyond. Nephrol Dial Transplant 2015;30:1972-8. [PMID: 25500804 DOI: 10.1093/ndt/gfu375] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
127 Immohr MB, Akhyari P, Aubin H, Westenfeld R, Mehdiani A, Bruno RR, Sipahi NF, Erbel-Khurtsidze S, Reinecke P, Tudorache I, Lichtenberg A, Boeken U. Treatment of donor-specific antibody-mediated rejection after heart transplantation by IgM-enriched human immunoglobulin. ESC Heart Fail 2021;8:3413-7. [PMID: 33969938 DOI: 10.1002/ehf2.13409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Lobashevsky AL. Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation. World J Transplant 2014; 4(3): 153-167 [PMID: 25346888 DOI: 10.5500/wjt.v4.i3.153] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
129 Althaf MM, El Kossi M, Jin JK, Sharma A, Halawa AM. Human leukocyte antigen typing and crossmatch: A comprehensive review. World J Transplant 2017; 7(6): 339-348 [PMID: 29312863 DOI: 10.5500/wjt.v7.i6.339] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
130 Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, Luznik L, Huang XJ, Ciceri F, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Handgretinger R, Roy DC, O'Donnell P, Bashey A, Lazarus HM, Ballen K, Savani BN, Mohty M, Nagler A. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplant 2018;53:521-34. [PMID: 29335625 DOI: 10.1038/s41409-017-0062-8] [Cited by in Crossref: 79] [Cited by in F6Publishing: 66] [Article Influence: 19.8] [Reference Citation Analysis]
131 Pavlakis M. Transplantation: early hospital readmissions after kidney transplantation. Nat Rev Nephrol 2014;10:188-9. [PMID: 24595039 DOI: 10.1038/nrneph.2014.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
132 Pearl MH, Leuchter RK, Reed EF, Zhang Q, Ettenger RB, Tsai EW. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies. Pediatr Nephrol 2015;30:1371-4. [PMID: 25956702 DOI: 10.1007/s00467-015-3123-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
133 Fernandez HE. Application and interpretation of histocompatibility data in pediatric kidney transplantation. Curr Opin Organ Transplant 2017;22:426-32. [PMID: 28542109 DOI: 10.1097/MOT.0000000000000425] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
134 Engen RM, Park GE, Schumacher CS, Gimferrer I, Warner P, Finn LS, Weiss NS, Smith JM. Donor-specific Antibody Surveillance and Graft Outcomes in Pediatric Kidney Transplant Recipients. Transplantation. 2018;102:2072-2079. [PMID: 29863579 DOI: 10.1097/tp.0000000000002310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
135 Lefaucheur C, Viglietti D, Mangiola M, Loupy A, Zeevi A. From Humoral Theory to Performant Risk Stratification in Kidney Transplantation. J Immunol Res 2017;2017:5201098. [PMID: 28133619 DOI: 10.1155/2017/5201098] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
136 Jalanko H, Pakarinen M. Combined liver and kidney transplantation in children. Pediatr Nephrol. 2014;29:805-14; quiz 812. [PMID: 23644898 DOI: 10.1007/s00467-013-2487-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
137 Rabant M, Amrouche L, Lebreton X, Aulagnon F, Benon A, Sauvaget V, Bonifay R, Morin L, Scemla A, Delville M, Martinez F, Timsit MO, Duong Van Huyen JP, Legendre C, Terzi F, Anglicheau D. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection. J Am Soc Nephrol. 2015;26:2840-2851. [PMID: 25948873 DOI: 10.1681/asn.2014080797] [Cited by in Crossref: 64] [Cited by in F6Publishing: 33] [Article Influence: 9.1] [Reference Citation Analysis]
138 Pape L, Becker JU, Immenschuh S, Ahlenstiel T. Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol. 2014;. [PMID: 24865478 DOI: 10.1007/s00467-014-2851-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
139 Mierzejewska B, Schroder PM, Baum CE, Blair A, Smith C, Duquesnoy RJ, Marrari M, Gohara A, Malhotra D, Kaw D, Liwski R, Rees MA, Stepkowski S. Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP. Hum Immunol 2014;75:703-8. [PMID: 24755353 DOI: 10.1016/j.humimm.2014.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
140 Platt JL, Cascalho M. Non-canonical B cell functions in transplantation. Hum Immunol 2019;80:363-77. [PMID: 30980861 DOI: 10.1016/j.humimm.2019.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
141 OʼLeary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, Cozzi E. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients. Transplantation 2016;100:39-53. [PMID: 26680372 DOI: 10.1097/TP.0000000000000869] [Cited by in Crossref: 73] [Cited by in F6Publishing: 21] [Article Influence: 12.2] [Reference Citation Analysis]
142 Snell GI, Westall GP, Paraskeva MA. Immunosuppression and allograft rejection following lung transplantation: evidence to date. Drugs 2013;73:1793-813. [PMID: 24142409 DOI: 10.1007/s40265-013-0136-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
143 Jolles S, Jordan SC, Orange JS, van Schaik IN. Immunoglobulins: current understanding and future directions. Clin Exp Immunol 2014;178 Suppl 1:163-8. [PMID: 25546806 DOI: 10.1111/cei.12555] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
144 Legris T, Picard C, Todorova D, Lyonnet L, Laporte C, Dumoulin C, Nicolino-Brunet C, Daniel L, Loundou A, Morange S, Bataille S, Vacher-Coponat H, Moal V, Berland Y, Dignat-George F, Burtey S, Paul P. Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies. Front Immunol 2016;7:288. [PMID: 27563301 DOI: 10.3389/fimmu.2016.00288] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
145 Phanish MK. Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation. Indian J Nephrol 2016;26:80-5. [PMID: 27051130 DOI: 10.4103/0971-4065.167275] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
146 Benzimra M, Calligaro GL, Glanville AR. Acute rejection. J Thorac Dis 2017;9:5440-57. [PMID: 29312755 DOI: 10.21037/jtd.2017.11.83] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
147 Pearl MH, Reed EF. Angiotensin II type I receptor antibodies in pediatric solid organ transplant. Hum Immunol 2019;80:568-72. [PMID: 30926351 DOI: 10.1016/j.humimm.2019.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
148 Attas RAA, Bader RM, Mashhour M, Alqahtani ZA, Mohammed A, Qahtani M, Arain ZB, Faraidy N, Awaji M, Mohammed G, Alharbi HA, Alzahrani M, Aqool A, Salim G. Graft‐versus‐host disease after pediatric liver transplantation: A diagnostic challenge. Pediatric Transplantation. [DOI: 10.1111/petr.14205] [Reference Citation Analysis]
149 Olszowska-Zaremba N, Gozdowska J, Sobierajska I, Zagożdżon R. Inactivation of IgM Antibodies as a Crucial Element of Diagnostics in Sensitized Patients Awaiting Kidney Transplant. Transplant Proc 2020;52:2268-72. [PMID: 32247595 DOI: 10.1016/j.transproceed.2020.02.085] [Reference Citation Analysis]
150 Peng B, Zhuang Q, Yu M, Li J, Liu Y, Zhu L, Ming Y. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation. Med Sci Monit 2019;25:952-61. [PMID: 30712055 DOI: 10.12659/MSM.914902] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
151 Krenzien F, ElKhal A, Quante M, Rodriguez Cetina Biefer H, Hirofumi U, Gabardi S, Tullius SG. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation. Transplantation 2015;99:2258-68. [PMID: 26244716 DOI: 10.1097/TP.0000000000000842] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 9.2] [Reference Citation Analysis]
152 Jordan SC, Glotz D. 7th International Immunoglobulin Conference: Transplantation. Clin Exp Immunol 2014;178 Suppl 1:46-7. [PMID: 25546758 DOI: 10.1111/cei.12507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Picascia A, Grimaldi V, Casamassimi A, De Pascale MR, Schiano C, Napoli C. Human leukocyte antigens and alloimmunization in heart transplantation: an open debate. J Cardiovasc Transl Res 2014;7:664-75. [PMID: 25190542 DOI: 10.1007/s12265-014-9587-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
154 Kahn J, Pregartner G, Avian A, Kniepeiss D, Müller H, Schemmer P. The Graz Liver Allocation Strategy-Impact of Extended Criteria Grafts on Outcome Considering Immunological Aspects. Front Immunol 2020;11:1584. [PMID: 32849538 DOI: 10.3389/fimmu.2020.01584] [Reference Citation Analysis]
155 Pankhurst L, Hudson A, Mumford L, Willicombe M, Galliford J, Shaw O, Thuraisingham R, Puliatti C, Talbot D, Griffin S, Torpey N, Ball S, Clark B, Briggs D, Fuggle SV, Higgins RM. The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants. Transplant Direct. 2017;3:e181. [PMID: 28706984 DOI: 10.1097/txd.0000000000000695] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
156 Menon MC, Murphy B, Heeger PS. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation. J Am Soc Nephrol 2017;28:735-47. [PMID: 28062570 DOI: 10.1681/ASN.2016080858] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
157 Pai A, Swan JT, Wojciechowski D, Qazi Y, Dholakia S, Shekhtman G, Abou-Ismail A, Kumar D. Clinical Rationale for a Routine Testing Schedule Using Donor-Derived Cell-Free DNA After Kidney Transplantation. Ann Transplant 2021;26:e932249. [PMID: 34210952 DOI: 10.12659/AOT.932249] [Reference Citation Analysis]
158 Chowdhry M, Makroo RN, Singh M, Kumar M, Thakur Y, Sharma V. Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India. J Immunol Res 2018;2018:3434050. [PMID: 29850626 DOI: 10.1155/2018/3434050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
159 Aziz F, Mandelbrot D, Parajuli S, Al-Qaoud T, Redfield R, Kaufman D, Odorico JS. Alloimmunity in pancreas transplantation. Curr Opin Organ Transplant 2020;25:322-8. [PMID: 32692039 DOI: 10.1097/MOT.0000000000000776] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG. Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients. Front Immunol 2018;9:3002. [PMID: 30631326 DOI: 10.3389/fimmu.2018.03002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
161 Snyder LD, Gray AL, Reynolds JM, Arepally GM, Bedoya A, Hartwig MG, Davis RD, Lopes KE, Wegner WE, Chen DF, Palmer SM. Antibody desensitization therapy in highly sensitized lung transplant candidates. Am J Transplant 2014;14:849-56. [PMID: 24666831 DOI: 10.1111/ajt.12636] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
162 Seifert ME, Agarwal G, Bernard M, Kasik E, Raza SS, Fatima H, Gaston RS, Hauptfeld-Dolejsek V, Julian BA, Kew CE, Kumar V, Mehta S, Ong S, Rosenblum F, Towns G, Mannon RB. Impact of Subclinical Borderline Inflammation on Kidney Transplant Outcomes. Transplant Direct 2021;7:e663. [PMID: 33511268 DOI: 10.1097/TXD.0000000000001119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Bray RA, Gebel HM, Townsend R, Roberts ME, Polinsky M, Yang L, Meier-Kriesche HU, Larsen CP. Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT. Am J Transplant 2018;18:1774-82. [PMID: 29573335 DOI: 10.1111/ajt.14738] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
164 Jayankura M, Schulz AP, Delahaut O, Witvrouw R, Seefried L, Berg BV, Heynen G, Sonnet W. Percutaneous administration of allogeneic bone-forming cells for the treatment of delayed unions of fractures: a pilot study. Stem Cell Res Ther 2021;12:363. [PMID: 34174963 DOI: 10.1186/s13287-021-02432-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Hachem RR. The role of the immune system in lung transplantation: towards improved long-term results. J Thorac Dis. 2019;11:S1721-S1731. [PMID: 31632749 DOI: 10.21037/jtd.2019.04.25] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
166 Wettstein D, Opelz G, Süsal C. HLA antibody screening in kidney transplantation: current guidelines. Langenbecks Arch Surg 2014;399:415-20. [PMID: 24271161 DOI: 10.1007/s00423-013-1138-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
167 Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG. Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival. Transplantation 2019;103:789-97. [PMID: 30106794 DOI: 10.1097/TP.0000000000002357] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
168 Lachmann N, Todorova K, Schulze H, Schönemann C. Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion. Transfus Med Hemother 2013;40:182-9. [PMID: 23922543 DOI: 10.1159/000351459] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]